Liver Cancer News

2025

January 2025

Love Your Liver: Blue Faery Amplifies Health Awareness During Black History Month

TACE Plus Camrelizumab and Apatinib Improves PFS in Liver Cancer Trial

Adjuvant Cell Therapy Reduces Recurrence Risk in Early-Stage Liver Cancer

Study: Bile Acid Supplement Shows Promise for Liver Cancer

Genetic Analysis Reveals PAH as a Risk Factor for Liver Cancer

Video: IMbrave050 Trial Design: Adjuvant Therapy for Early-Stage Hepatocellular Carcinoma

Promising Results for Triplet Blockade Therapy in Unresectable Hepatocellular Carcinoma

An International Project Involving IBB-CSIC-IDIBAPS Aims To Study The Relationship Between Hypercaloric Diets And Liver Cance

An Energy Trap For Tumor Cells: Researchers Find Enzyme Blockade Halts Liver Cancer Growth

NiKang Therapeutics® Announces First Patient Dosed in a Phase 1b/2 Study of NKT2152 in Combination with Standard-of-Care in First-Line Regimen for Hepatocellular Carcinoma

TACE Plus Lenvatinib/Pembrolizumab Boosts PFS in Unresectable Liver Cancer

Death Rates From Liver Cancer Double In The Last 20 Years

New Research Sheds Light On Changing Liver Cancer Trends

Breakthrough Treatment for Liver Cancer Shows Big Promise in Global Study

FDA Grants Orphan Drug Designation to Amezalpat in Hepatocellular Carcinoma

Abbreviated MRI for Hepatocellular Carcinoma: What a New Meta-Analysis Reveals

Study Reveals How Fatty Liver Disease Leads To Liver Cancer

For past liver cancer news, please visit our Liver Cancer News Archives.